| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 12/27/2001 | CA2635452A1 Looped probe design to control hybridization stringency |
| 12/27/2001 | CA2414228A1 Secreted epithelial colon stromal-1 polypeptides, nucleic acids encoding the same and uses thereof |
| 12/27/2001 | CA2414065A1 Cgi-69 compositions and methods of use |
| 12/27/2001 | CA2414062A1 Frozen tissue microarrays and methods for using the same |
| 12/27/2001 | CA2414033A1 Control of metabolism with compositions of the human 2-oxoglutarate carrier |
| 12/27/2001 | CA2414015A1 Human receptors |
| 12/27/2001 | CA2414010A1 Secreted redox proteins |
| 12/27/2001 | CA2413986A1 Gp354 nucleic acids and polypeptides |
| 12/27/2001 | CA2413866A1 Compositions and methods of monoclonal and polyclonal antibodies specific for t cell subpopulations |
| 12/27/2001 | CA2413454A1 A g-protein coupled receptor |
| 12/27/2001 | CA2413451A1 Methods of identifying gabab receptor subtype-specific agonists |
| 12/27/2001 | CA2413435A1 A recombinant cell line expressing gpcrx11 as a functional receptor validated by angiopeptin and useful for screening of agonists and antagonists |
| 12/27/2001 | CA2413324A1 Treatment of central nervous system diseases by antibodies against glatiramer acetate |
| 12/27/2001 | CA2413081A1 Agonist versus antagonist binding to g protein-coupled receptors |
| 12/27/2001 | CA2412827A1 Particles and their use in molecular imprinting |
| 12/27/2001 | CA2412736A1 Interaction of tbx2 and the arf promoter in cell cycle regulator assays |
| 12/27/2001 | CA2412484A1 G-protein coupled receptors |
| 12/27/2001 | CA2412375A1 Computational system for modelling protein expression in an organ |
| 12/27/2001 | CA2411978A1 Transgenic mice containing targeted gene disruptions |
| 12/27/2001 | CA2411971A1 Proteases |
| 12/27/2001 | CA2411912A1 Compositions and methods for treatment of candidiasis |
| 12/27/2001 | CA2411838A1 Protein expression profiling |
| 12/27/2001 | CA2411834A1 Enzyme detection and measurement |
| 12/27/2001 | CA2411756A1 Mutation associated with epilepsy |
| 12/27/2001 | CA2410857A1 Matrix screening method |
| 12/27/2001 | CA2410519A1 System and method for evaluating pockets in protein |
| 12/27/2001 | CA2410371A1 Methods for enhancing antibody-induced cell lysis and treating cancer |
| 12/27/2001 | CA2409781A1 Phosphodiesterases |
| 12/27/2001 | CA2409778A1 Secreted proteins |
| 12/27/2001 | CA2409776A1 G-protein coupled receptors |
| 12/27/2001 | CA2408630A1 Novel enterokinase cleavage sequences |
| 12/26/2001 | CN1328641A Nanoparticles with polymer shells |
| 12/26/2001 | CN1328640A Process and apparatus for use in vitro detection of multiple analytes |
| 12/26/2001 | CN1328638A Optical-based sensing devices |
| 12/26/2001 | CN1328604A Method for DNA or RNA sequencing |
| 12/26/2001 | CN1328603A Methods for identifying multiple primary targets of drug |
| 12/26/2001 | CN1328601A Methods and systems for predicting protein function |
| 12/26/2001 | CN1328571A Human monoclonal antibodies to CTLA-4 |
| 12/26/2001 | CN1328567A Mammaglobin, a secreted mammary-specific breast cancer protein |
| 12/26/2001 | CN1328476A Disposable article having bodily waste component sensor |
| 12/26/2001 | CN1328456A Use of thiazolidinediones derivatives for preventing uterine contractions in premature labour or lactation |
| 12/26/2001 | CN1328432A Method and apparatus for signal transmission and detection using contact device |
| 12/26/2001 | CN1328261A Method for detecting phosphoric acid radical in boiler water of electric power plant |
| 12/26/2001 | CN1328260A Integrated immune biochip, electric signal pick-up interface and its preparing process |
| 12/26/2001 | CN1328259A Oxidized haematine solution and its preparing process and application |
| 12/26/2001 | CN1328258A Electrochemical sensor with intensifed reproducibility |
| 12/26/2001 | CN1328156A Process for preparing fusion protein used for glucose sensor |
| 12/26/2001 | CN1076829C Method for quick measurement of bacterial content in circulating water |
| 12/26/2001 | CN1076827C Sampling container for analysing molten metal |
| 12/26/2001 | CA2350043A1 Novel melanocortin -4 receptor sequences and screening assays to identify compounds useful in regulating animal appetite and metabolic rate |
| 12/26/2001 | CA2348303A1 System and method for measurement of adhesive resin distribution on wood flakes using a scanner |
| 12/25/2001 | US6334091 Apparatus and method for sensing solute concentration |
| 12/25/2001 | US6333397 Hybridoma cell culture; for use in generation of preferential immunoglobulin which binds preferential muscle protein; for use in diagnosis of heart defects |
| 12/25/2001 | US6333395 Exhibit anti-membrane fusion capability, antiviral activity, such as the ability to inhibit hiv transmission to uninfected cells |
| 12/25/2001 | US6333312 Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases |
| 12/25/2001 | US6333306 Pharmaceutical combination preparations containing erythropoietin and iron preparations |
| 12/25/2001 | US6333200 Miniaturized immunosensor assembled from colloidal particles between micropatterned electrodes |
| 12/25/2001 | US6333198 Assaying sample of lamotrigine or a pharmaceutical dosage form comprising lamotrigine in presence of n-(5-amino-6-(2,3-dichlorophenyl)-1,2,4-triazin-3-yl)-2, 3-dichlorobenzamide |
| 12/25/2001 | US6333197 Distilling and separation of blood; withdrawl blood, mix with reageant, separate into containers, recover mixture, duplicate process for second fraction |
| 12/25/2001 | US6333167 Culturing eukaryotic cells that express a chimeric protein attached to a non-nuclear membrane and contains transcription repressor and a protease recognition sites; add test compound and monitor reporter gene expression; therapy for alzheimers |
| 12/25/2001 | US6333163 Method of facilitating HIV-1 infection through human leukotriene B4 receptor |
| 12/25/2001 | US6333162 Method for measuring cholinesterase and method for distinguishing between liver cirrhosis and hepatitis |
| 12/25/2001 | US6333161 Assaying a test ligands ability to bind a central nervous system receptor by incubation the ligand with mutant cells that produce a kainate-binding excitatory amino acid receptor and determining the extent of binding |
| 12/25/2001 | US6333160 A quantitave monitoring method that determines the upper limit of normal alpha sub.1-acid glycoprotein values in a selected body fluid of a selected species of animals |
| 12/25/2001 | US6333156 A sequence determiniation method for a plurality of nucleic acid analytes in a short period using nucleic acid analytes oligonucleotide fragments with base-specifically fragmented ends and labeled with different fluorescent labels |
| 12/25/2001 | US6333154 A amplification system with a chimeric polypeptide fragment from adenylate cyclase and guanylate cyclase fused to target molecue, a second different chimeric fragment fused to a ligand; screening substance interactions in bacterial cells |
| 12/25/2001 | US6333152 Gene expression profiles in normal and cancer cells |
| 12/25/2001 | US6333149 NMR-solve method for rapid identification of bi-ligand drug candidates |
| 12/25/2001 | US6333055 Use of ammonium compounds and/or urea |
| 12/25/2001 | US6333034 Administering anti-properdin agent effective to selectively inhibit formation of an alternative complement pathway activation product |
| 12/25/2001 | US6333033 Autoantibody inhibitors |
| 12/25/2001 | US6333031 Receptor derived peptides as modulators of receptor activity |
| 12/25/2001 | US6333008 Measuring system and method for performing luminometric series analyses as well as multiple cuvette for receiving liquid samples therefor |
| 12/25/2001 | US6332951 Quantitative analysis of chemicals for bleaching cellulose |
| 12/25/2001 | US6332369 Device for collecting gas in sealed containers that are to be controlled |
| 12/25/2001 | US6332364 Universal mechanical testing device |
| 12/25/2001 | US6332363 Biosensor, method of forming and use |
| 12/25/2001 | US6332351 Detection of salt content of water through measurement of radiation attenuation |
| 12/25/2001 | US6332349 Installation for analyzing an atmosphere |
| 12/25/2001 | CA2160982C Methods for determining platelet function |
| 12/25/2001 | CA2049231C Analytical method using tetrazolium salt indicators having a reflectance plateau |
| 12/25/2001 | CA2026515C Immunoassay using magnetic particle |
| 12/25/2001 | CA1341328C Sex-associated membrane proteins and methods for increasing the probability that offspring will be of a desired sex |
| 12/23/2001 | CA2351279A1 Fuel cell gas sensors |
| 12/23/2001 | CA2312259A1 Fuel cell gas sensors |
| 12/20/2001 | WO2001097098A2 Computational molecular docking methods for assessing complementarity of combinatorial libraries to biotargets |
| 12/20/2001 | WO2001096895A1 Method for investigating the fate of a test compound or the stateof a biological system by means of nmr of hyperpolarised nmr active nuclei |
| 12/20/2001 | WO2001096882A1 Measuring instrument comprising cartridge container, measuring method, and program recorded medium |
| 12/20/2001 | WO2001096879A2 Method and apparatus for monitoring anti-platelet agents |
| 12/20/2001 | WO2001096878A2 Marker for neurodegerative diseases and its use in drug screening |
| 12/20/2001 | WO2001096877A2 Rare earth metal cryptates showing reduced fluorescence quenching |
| 12/20/2001 | WO2001096876A1 Immunological test and diagnostic kit for prostate adenocarcinoma |
| 12/20/2001 | WO2001096875A2 Hcv antigen/antibody combination assay |
| 12/20/2001 | WO2001096874A1 Method for identifying compounds with anti-herpes activity |
| 12/20/2001 | WO2001096873A2 Method for identifying apoptosis-modified proteins |
| 12/20/2001 | WO2001096871A2 Recombinant phycobiliprotein and phycobiliprotein linker fusion proteins and uses therefore |
| 12/20/2001 | WO2001096870A2 Immunoassays for anti-hcv antibodies |
| 12/20/2001 | WO2001096869A1 Selective labeling and isolation of phosphopeptides and applications to proteome analysis |
| 12/20/2001 | WO2001096868A2 Immunoassay and immunoassay apparatus |
| 12/20/2001 | WO2001096867A2 Method for identifying insulin mimics or antagonists |